Standard Care With LLLT & Myofascial Release Versus Standard Care Alone in Pregnant Women With Temporomandibular Disorder
Standard Care Combined With Low-Level Laser Therapy and Myofascial Release Versus Standard Care Alone in Pregnant Women With Temporomandibular Disorder: A Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Giza
-
Al Ḩayy Ath Thāmin, Giza, Egypt, 12511
- October 6 university hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women diagnosed with myofascial TMD according to the Research Diagnostic Criteria for Temporomandibular Disorders
Exclusion Criteria:
- facial neuro-musculoskeletal pathologies (i.e., facial trauma and/or fractures, and bell's palsy)
- acute infections or systemic disorders
- osteoporosis
- cervical spine or upper limb dysfunction
- steroid infiltration4
- any recent dental treatment taken or surgery over TMJ
- hypermobile joint
- neurological impairments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Control group
Patients received a 4-week treatment program (12 treatment sessions, three times a week).
Patients received the conservative treatment protocol comprised of ultrasound, hot pack application, and exercises.
|
Active exercises for mandibular muscles will be used to correct the mouth opening
|
|
Experimental: Intervention group
Patients received a 4-week treatment program (12 treatment sessions, three times a week).
Patients received LLLT and myofascial release combined with the control intervention.
the conservative treatment protocol comprised of ultrasound, hot pack application, and exercises
|
Active exercises for mandibular muscles will be used to correct the mouth opening
MLS® device (ASA Srl, Vicenza, Italy) IR laser with two synchronized sources (laser diodes) and a wavelength of 808 nm to deliver the intervention.
The laser probe will be held vertically in contact with the skin to deliver the irradiation at three mandibular condyle points (front, behind and over) and one point at the external acoustic meatus.
The irradiation will be applied with a laser bean of 3.14 cm² diameter for 14 seconds at each place using a pulse rate of 1500 Hz, pulse duration of 100ns, and energy density: 16 J/cm².
Patients will be positioned in supine in a treatment table.
The therapist seated beside the patient at the side of affected temporomandibular joint to apply gross release technique for masseter, pterygoid and temporalis muscles.
At each point, the therapist applied the technique for 90 seconds and repeated 5 times during the session (5 seconds of rest between each repetition).(15)
The therapist worn gloves to deliver the intraoral myofascial release.
In case the patient reported any latex allergies, the gloves were replaced by a latex free model.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in visual analogue scale
Time Frame: Baseline and after 4 weeks
|
Visual analog scale (VAS), a grading scale range from 0 to 100 mm.
0 mm represented no pain or discomfort at all and 100 mm represented the greatest amount of pain or discomfort imaginable.
Participant drew a line that intersects the grading scale to show the amount of pain or discomfort that he or she experienced at that moment.
The assessor then used a ruler to measure the length from 0 mm to the intersecting line and recorded the value.
|
Baseline and after 4 weeks
|
|
Changes in pain pressure threshold (PPT)
Time Frame: Baseline and after 4 weeks
|
Comparing pain pressure threshold differences on both sides over TMJ, masseter and anterior temporalis.
|
Baseline and after 4 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Limitations of daily function in temporomandibular disorder questionnaire
Time Frame: Baseline and after 4 weeks
|
The limitations in daily functions in the temporomandibular disorder questionnaire (LDF-TMDQ) assess participants' functionality by asking them to report how much the jaw problem prevents or limits their performance in a list of 10 daily activities
|
Baseline and after 4 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Radwa M Yehia, Ph.D, Faculty of Physical Therapy, October 6 University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PTMD2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.